Q-omics provides the consensus-scored SNRPEP4 profile across patient tissues and cancer cell-line models. SNRPEP4 expression is associated with patient survival in 30 of 34 cancer types, with the highest sampling consensus in ACC. Among the 18 cancer types available for tumor–normal comparison, SNRPEP4 is differentially expressed in 14, with the highest sampling consensus in COAD. Additionally, SNRPEP4 RNA expression shows 16,860 significant gene co-expression associations, with the highest sampling consensus in ACC. Together, these results highlight ACC, and COAD as cancer lineages where SNRPEP4 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for SNRPEP4 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes SNRPEP4 survival associations across molecular data types. SNRPEP4 RNA expression shows survival associations in the most cancer types (30). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible SNRPEP4 RNA expression–survival associations across cancer types. High SNRPEP4 expression shows unfavorable associations in ACC, LIHC, LUAD, BRCA, PAAD and KIRC. The ACC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify ACC as the clearest survival context for SNRPEP4 RNA expression.
This table summarizes SNRPEP4 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 14. The strongest signals are observed in KIRC for RNA.
This table ranks reproducible tumor–normal expression differences for SNRPEP4. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. SNRPEP4 shows higher tumor expression in COAD, KIRC, LUAD, HNSC, LIHC and LUSC. The COAD box plot shows higher SNRPEP4 RNA expression in tumor versus normal tissue (log2 FC = +1.454, t-test p < 0.001).
This table shows molecular features associated with SNRPEP4 in patient tissues and cancer cell lines. In patient samples, SNRPEP4 shows the broadest associations at the RNA and protein expression levels, with ACC recurring as the lineage with the largest associated feature set.
